Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
July 29, 2020 at 04:09 pm EDT
Enzon Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 8,000 compared to USD 207,000 a year ago. Operating loss was USD 236,000 compared to USD 21,000 a year ago. Net loss was USD 236,000 compared to USD 21,000 a year ago. Basic loss per share from continuing operations was USD 0.01. For the half year, total revenue was USD 10,000 compared to USD 156,000 a year ago. Operating loss was USD 476,000 compared to USD 390,000 a year ago. Net loss was USD 478,000 compared to USD 392,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.